| Name | Title | Contact Details |
|---|
Cimplifi is a leading integrated legal services provider, leveraging technology and expertise to simplify the experience of eDiscovery and contract analytics for law firms and legal departments. Our client-centric ecosystem and experience offer a curated portfolio of technology-enabled solutions that integrates proprietary tools and automated workflows with market-leading software to deliver an easy-to-use, end-to-end system that streamlines processes, unifies reporting, and empowers users. For more than two decades, clients have relied on our expertise and ingenuity to solve complex challenges, bring innovative solutions, and deliver intelligence and insight to help them manage risk, control costs, and get more done, more effectively and with far less effort and stress. Cimplifi is ISO 27001 certified and is a division of System One. Learn more at www.cimplifi.com.
XNRGY Climate Systems is a Montreal-based company that designs, develops, and manufactures HVAC systems with a strong emphasis on energy efficiency and sustainability. Founded in 2017, the company aims to lead North America in sustainable design and advanced manufacturing of custom air handling systems, particularly for data centers, healthcare facilities, clean rooms, and life sciences environments. The company offers custom-engineered air handling units tailored to meet specific project requirements, focusing on reducing power usage effectiveness and carbon footprints. XNRGY specializes in thermal management solutions, ensuring optimal cooling and heating for mission-critical facilities. Its product lineup includes custom air handlers, energy recovery systems, and specialized materials designed to meet demanding specifications. XNRGY serves a diverse clientele, including major cloud and hyperscale data center operators, healthcare facilities, and life sciences organizations, ensuring high standards of air quality and efficiency.
Tower International now AUTOKINITON! Autokiniton pursues strategic investments in respected Tier 1 automotive suppliers. Through innovative solutions and services, our subsidiaries advance the trends that define the automotive industry of today and tomorrow. In May 2018, Autokiniton was formed by KPS Capital Partners and George Thanopoulos (Autokiniton Chairman & CEO) to acquire L&W Group. L&W Group is a leading Tier 1 supplier in the automotive industry specializing in metal stampings, welded assemblies, and tubular products. In September of 2019, Autokiniton acquired Tower International, a leading Tier 1 manufacturer of structural metal automotive components and supplier of metal stampings, welded assemblies, frame structures, and chassis structures. This merger of L&W Group and Tower International has created the No. 2 Body-In-White and vehicle-frame supplier in North America, providing value-driven, sustainable automotive components and assembly solutions for our customers in the mobility industry. Our dedication to teamwork, speed, simplification, performance, and empowering our associates has made us a trusted partner to the worlds top automotive OEMs. Autokinitons legacy of operational excellence, high-quality execution, and customer service ensures that every project – no matter how challenging -- is in the best possible hands.
At POCN, we seek to support the careers and clinical practices of NPs and PAs - Advanced Clinicians by partnering with life science companies who recognize their critical role on the front lines of healthcare. We are the largest network of Advanced Clinicians in the U.S. and strive to support and enable success for them at every turn. POCN provides Advanced Clinicians with an opportunity engine to grow their careers, earn valuable financial incentives, and increase their clinical knowledge and practice productivity. Recognizing the vital relationship between NPs, PAs, and the broader healthcare and life sciences industries, POCN specializes in developing peer–validated programs that include engaging live and virtual events, helpful patient education resources, incentivized market research programs, clinical reference and prescribing tools, promoted speaking opportunities, as well as CME and continuous learning modules on a variety of disease states and therapies.